By elucidating the mechanistic role of MAPK/ERK in RA, this article aims to highlight the pathway’s therapeutic relevance and provide a foundation for the developing more effective, targeted therapies for RA. This evidence concerns the gene MAPK1 and rheumatoid arthritis.